Taro Company Profile
✉ Email this page to a colleague
What is the competitive landscape for TARO, and what generic alternatives to TARO drugs are available?
TARO has two hundred and fifty-three approved drugs.
There are eight US patents protecting TARO drugs. There are five tentative approvals on TARO drugs.
There are thirty-one patent family members on TARO drugs in twelve countries and one hundred and seventy-two supplementary protection certificates in fourteen countries.
Summary for Taro
International Patents: | 31 |
US Patents: | 8 |
Tradenames: | 133 |
Ingredients: | 116 |
NDAs: | 253 |
Patent Litigation for Taro: | See patent lawsuits for Taro |
PTAB Cases with Taro as petitioner: | See PTAB cases with Taro as petitioner |
Drugs and US Patents for Taro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | IMIQUIMOD | imiquimod | CREAM;TOPICAL | 200173-001 | Apr 15, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | MICONAZOLE NITRATE | miconazole nitrate | CREAM;VAGINAL | 074444-001 | Jan 13, 1997 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Taro | ACETAMINOPHEN | acetaminophen | SUPPOSITORY;RECTAL | 018337-003 | Sep 12, 1983 | OTC | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Taro Pharm Inds | AMCINONIDE | amcinonide | CREAM;TOPICAL | 076229-001 | May 31, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | DAPSONE | dapsone | GEL;TOPICAL | 210191-001 | Jun 26, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Taro | THEOPHYLLINE | theophylline | ELIXIR;ORAL | 089626-001 | Oct 28, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Taro
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Taro | PLIAGLIS | lidocaine; tetracaine | CREAM;TOPICAL | 021717-001 | Jun 29, 2006 | 5,919,479 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,071,523 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 5,881,926 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,399,079 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-002 | Jan 17, 2008 | 6,102,254 | ⤷ Try a Trial |
Taro | FLO-PRED | prednisolone acetate | SUSPENSION;ORAL | 022067-001 | Jan 17, 2008 | 6,399,079 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for TARO drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 1909798 | ⤷ Try a Trial |
European Patent Office | 1888026 | ⤷ Try a Trial |
China | 101287374 | ⤷ Try a Trial |
China | 102834096 | ⤷ Try a Trial |
Canada | 2822220 | ⤷ Try a Trial |
European Patent Office | 2523660 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Taro Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0428642 | 57/2007 | Austria | ⤷ Try a Trial | PRODUCT NAME: DOCOSANOL; NAT. REGISTRATION NO/DATE: 1-27014 20070518; FIRST REGISTRATION: SE 18517 20031114 |
1429780 | SPC/GB12/058 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
1586316 | 122011100019 | Germany | ⤷ Try a Trial | PRODUCT NAME: BROMFENAC (2-AMINO-3-(4-BROMOBENZOYL)PHENYLESSIGSAEURE); REGISTRATION NO/DATE: EU/1/11/692/001 20110518 |
1620113 | 300756 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: IVERMECTINE VOOR TOEPASSING IN DE BEHANDELING VAN ROSACEA; NATIONAL REGISTRATION NO/DATE: RVG 115310 20150504; FIRST REGISTRATION: MT MA117/01101 20150402 |
1586316 | C 2011 004 | Romania | ⤷ Try a Trial | PRODUCT NAME: BROMFENAC, SARURILE SI HIDRATII SAI ACCEPTABILI FARMACEUTICACID 2-[2-AMINO-3-(4-BROMOBENZOIL)FENILACETIC; NATIONAL AUTHORISATION NUMBER: RO EU/1/11/692/001; DATE OF NATIONAL AUTHORISATION: 20110518; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EMEA EU/1/11/692/001; DATE OF FIRST AUTHORISATION IN EEA: 20110518 |
0347066 | 42/2002 | Austria | ⤷ Try a Trial | PRODUCT NAME: ESCITALOPRAM UND DESSEN NICHT-TOXISCHE SAEUREADDITIONSSALZE; NAT. REGISTRATION NO/DATE: 1-24549, 1-24550, 1-24551, 1-24552 20020618; FIRST REGISTRATION: SE 17084, 17085, 17086,17087 20011207 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.